Trial Profile
A phase I clinical trial to evaluate the safety, tolerability, and pharmacodynamics of AST-005 in patients with chronic plaque psoriasis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 May 2018
Price :
$35
*
At a glance
- Drugs AST 005 (Primary)
- Indications Plaque psoriasis
- Focus Adverse reactions
- 30 Apr 2018 Results presented in an Exicure media release.
- 12 Dec 2016 According to a Purdue Pharma media release, status changed from recruiting to completed.
- 29 Apr 2016 New trial record